CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
$78.9M |
| 2 |
Biogen
BIIB
|
$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$63.8M |
| 4 |
Merck
MRK
|
$58M |
| 5 |
Gilead Sciences
GILD
|
$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$26.1M |
| 2 |
iRobot
IRBT
|
$15.5M |
| 3 |
Quest Diagnostics
DGX
|
$15.1M |
| 4 |
Colgate-Palmolive
CL
|
$14.9M |
| 5 |
Philip Morris
PM
|
$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Crown Castle
CCI
$41.9B
| $3.24M | 0.04% |
29,108
-327
| -1% | -$36.4K |
|
|
ONCE
402
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.22M | 0.04% |
59,100
+28,700
| +94% | +$1.57M |
|
403
Northern Trust
NTRS
$24.3B
| $3.12M | 0.04% |
30,516
-1,276
| -4% | -$130K |
|
404
Huntington Bancshares
HBAN
$25.7B
| $3.08M | 0.04% |
206,350
-58,996
| -22% | -$880K |
|
405
Lumen
LUMN
$4.87B
| $3.08M | 0.04% |
145,233
+9,120
| +7% | +$193K |
|
406
Campbell Soup
CPB
$10.1B
| $3.06M | 0.04% |
83,510
+9,100
| +12% | +$333K |
|
407
General Motors
GM
$55.5B
| $3.05M | 0.04% |
90,539
+5,146
| +6% | +$173K |
|
408
Madrigal Pharmaceuticals
MDGL
$9.65B
| $2.99M | 0.04% |
13,950
+4,550
| +48% | +$974K |
|
409
Kroger
KR
$44.8B
| $2.97M | 0.04% |
102,115
+10,289
| +11% | +$300K |
|
410
Public Storage
PSA
$52.2B
| $2.96M | 0.04% |
14,685
+1,442
| +11% | +$291K |
|
411
Dell
DELL
$84.4B
| $2.91M | 0.04% |
106,808
+14,146
| +15% | +$386K |
|
412
Halozyme
HALO
$8.76B
| $2.91M | 0.04% |
160,000
+13,000
| +9% | +$236K |
|
413
Baxter International
BAX
$12.5B
| $2.88M | 0.04% |
37,406
-742
| -2% | -$57.2K |
|
414
Ametek
AME
$43.3B
| $2.87M | 0.04% |
36,265
-448
| -1% | -$35.4K |
|
415
Principal Financial Group
PFG
$17.8B
| $2.86M | 0.04% |
48,760
-15,671
| -24% | -$918K |
|
416
Manulife Financial
MFC
$52.1B
| $2.86M | 0.04% |
159,807
-4,366
| -3% | -$78K |
|
417
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.82M | 0.04% |
135,700
+3,700
| +3% | +$76.8K |
|
418
Enbridge
ENB
$105B
| $2.76M | 0.04% |
85,682
+1,320
| +2% | +$42.6K |
|
419
Constellation Brands
STZ
$26.2B
| $2.74M | 0.04% |
12,684
+280
| +2% | +$60.4K |
|
420
SBA Communications
SBAC
$21.2B
| $2.73M | 0.04% |
17,002
-145
| -0.8% | -$23.3K |
|
421
Fiserv
FI
$73.4B
| $2.72M | 0.04% |
33,054
-1,151
| -3% | -$94.8K |
|
422
ServiceNow
NOW
$190B
| $2.7M | 0.04% |
13,794
-1,261
| -8% | -$247K |
|
423
KLA
KLAC
$119B
| $2.69M | 0.04% |
26,489
-63,426
| -71% | -$6.45M |
|
424
T Rowe Price
TROW
$23.8B
| $2.68M | 0.04% |
24,556
-1,125
| -4% | -$123K |
|
425
Cencora
COR
$56.7B
| $2.66M | 0.04% |
28,845
+1,325
| +5% | +$122K |
|